Anti-Fungal Treatment Market Size, Share, and Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Route of Administration (Oral, Topical, and Parenteral), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), B

Anti-Fungal Treatment Market Size, Share, and Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Route of Administration (Oral, Topical, and Parenteral), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032

PRODUCT OVERVIEW

Anti-Fungal Treatment Market is expected to grow at a CAGR of 3.3% in the forecast period (2023-2032), with the market size valued at USD 12.27 billion in 2021 and projected to reach USD 17.4 billion by 2032.

Fungi are microorganisms that can survive in a variety of conditions and cause different type of illnesses in people, ranging from skin infections to systemic infections by inhalation. These illnesses are frequently caused by exposure to unsanitary conditions or by impaired immune systems. As a result, people may have fungal infections on their skin, hair, and lungs, fueling market expansion. This proliferation is being aided by common fungal infections such as ringworm, athlete's foot, and fungal nail infections. Antifungal medications are critical in avoiding fungal growth and infection especially over-the-counter choices for skin infections, is favorably boosting the growth of the antifungal drug industry.

MARKET HIGHLIGHTS

Anti-Fungal Treatment Market is expected to reach USD 17.4 billion, growing at a CAGR of 3.3% owing to the global rise in the occurrence of fungal infections that has driven producers to create enhanced formulation drugs for better clinical outcomes. This, in turn, is fuelling market expansion throughout the predicted period. As a result, producers are focused on new drug formulations that can be manufactured utilizing nanotechnology.

Anti-Fungal Treatment Market Segments:

• By Drug Type
• Echinocandins
• Azoles
• Polyenes
• Allylamines
• By Route of Administration
• Oral
• Topical
• Parenteral
• By Indication
• Dermatophytosis
• Aspergillosis
• Candidiasis
• Others
• By Distribution Channel
• Hospital Pharmacies
• Retails Pharmacies & Drug Stores
• Others

MARKET DYNAMICS

Growth Drivers

Increase in Nosocomial Infections to Boost the Market for Antifungal Drugs

Increased R&D efforts are Expected to Boost the Market Growth

Restraint

High Adverse Effects and the Use of Conventional Drugs is Hurting the Market

Key Players

• Pfizer Inc.
• Gilead Sciences, Inc.
• Merck & Co., Inc.
• Astellas Pharma Inc.
• GlaxoSmithKline plc.
• AbbVie Inc.
• Novartis AG
• Johnson & Johnson
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Sanofi S.A.
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Basilea Pharmaceutica AG
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

*Please Note: The report will be delivered in 4-5 business days upon order confirmation*